Acebilustat

Definition:
Acebilustat is a novel small-molecule inhibitor of leukotriene A4 hydrolase (LTA4H), which plays a key role in inflammatory responses. It is being developed for the treatment of chronic inflammatory diseases.

Function:
Acebilustat helps reduce inflammation by inhibiting LTA4H activity, which decreases the production of pro-inflammatory leukotrienes. It has potential benefits in treating diseases such as cystic fibrosis, chronic obstructive pulmonary disease (COPD), and other inflammatory disorders.

Application:
Acebilustat is primarily used in pharmaceutical research and drug development for inflammatory disease treatments. It is available in oral dosage forms for clinical studies and potential therapeutic applications.